Videos de Experimentos Relacionados

Patología celular basada en la evidencia.

Kenneth A Fleming¹

¹University of Oxford, Medical School Office, Level 3, John Radcliffe Hospital, Headington, OX3 9DU, Oxford, UK.

Lancet (London, England)

|April 12, 2002

Resumen

No abstract available in PubMed .

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics.

Lancet (London, England)·2025

Same author

A World Health Assembly resolution on diagnostics: what pathologists should know and do.

Histopathology·2024

Same author

A world health assembly resolution on diagnostics: implications for the ESCMID community.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2023

Same author

Improved pathology reporting in NAFLD/NASH for clinical trials.

Journal of clinical pathology·2021

Same author

The Lancet Commission on diagnostics: transforming access to diagnostics.

Lancet (London, England)·2021

Same author

A dream of spring - the Lancet Commission on diagnostics.

Histopathology·2019

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

Patología celular basada en la evidencia.

Videos de Conceptos Relacionados

Artículos Relacionados

Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics.

A World Health Assembly resolution on diagnostics: what pathologists should know and do.

A world health assembly resolution on diagnostics: implications for the ESCMID community.

Improved pathology reporting in NAFLD/NASH for clinical trials.

The Lancet Commission on diagnostics: transforming access to diagnostics.

A dream of spring - the Lancet Commission on diagnostics.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Videos de Experimentos Relacionados

Patología celular basada en la evidencia.

Videos de Conceptos Relacionados

Artículos Relacionados

Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics.

A World Health Assembly resolution on diagnostics: what pathologists should know and do.

A world health assembly resolution on diagnostics: implications for the ESCMID community.

Improved pathology reporting in NAFLD/NASH for clinical trials.

The Lancet Commission on diagnostics: transforming access to diagnostics.

A dream of spring - the Lancet Commission on diagnostics.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.